TERAZOSIN

SynDRA canonical compound SYN0001152 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	ADRA1A
Mechanism of action	Adrenergic receptor antagonist
Indication	benign prostatic hyperplasia (BPH) \| hypertension
Disease area	cardiology \| urology

All known targets

terazosin hydrochloride
terazosin hydrochloride anhydrous
terazosine
terazosin hydrochloride hydrate
terazosin HCl
Terazosine
Terazosina
Terazosabb
Blavin
Flumarc
Fosfomic
Hytracin
Hytrin
Terazosinum
Vasomet
Trazosin HCl
A-45975
Abbott 45975
Hytrin (TN)
Terazosabb (TN)
Terazosin (INN)
Terazosin [INN:BAN]
Terazosina [INN-Spanish]
Terazosine [INN-French]
Terazosinum [INN-Latin]
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](tetrahydrofuran-2-yl)methanone
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine
6,7-bis(methyloxy)-2-[4-(tetrahydrofuran-2-ylcarbonyl)piperazin-1-yl]quinazolin-4-amine
6,7-dimethoxy-2-[4-(tetrahydrofuran-2-ylcarbonyl)piperazin-1-yl]quinazolin-4-amine
8L5014XET7
terazocin
Hytrinex
Vicard
CHEBI:9445
RefChem:57178
DTXCID003639